Welcome to our newest sites open to recruitment in Oxford, Lewisham & Aintree.
We are still looking for further recruiting sites. If you are interested, please get in touch.
๐จ Great team effort to recruit @LivHospitals first patient to the Early Vasopressors in Sepsis (EVIS) trial @evis_trial - Improving the care delivered to early sepsis patients. @LivHospitalsRI @NIHRresearch @LivHospitalsRI ๐จ
Huge thanks to staff and sites recruiting patients to @evis this month
Hull Royal Infirmary
Edinburgh @emerge_research
Kettering @ResearchKgh
Derby @UHDBTrust
Victoria Hospital @VHK_FifeEM
St Georgeโs @StGeorgesTrust
Royal London @RoyalLondonHosp
No photos as we were busy talking - but so good to see everyone at the investigators meeting today at #rcemasc23
Thanks everyone for coming and great discussions about the way forward for EVIS
June has been the busiest month for #EVIS since the study opened. Twice as many participants recruited this month compared to previous busiest month.
Big thanks to all recruiting sites and teams, but most of all participants and their families.
We had our busiest recruiting day for the @evis_trial recently with 3 patients recruited in a single day.
Thanks to all recruiting sites, patients and their families
Further data regarding safety of peripheral vasopressors. โฌ๏ธ
We will be also be reporting specific safety outcome data on peripheral vasopressor use in the EVIS trial.
Fluids. CLOVERS โ๏ธโ๏ธโ๏ธ Trial. Published recently in NEJM. Nice presentation except for frequent use of their term โlevophedโ by @com543 ๐ - takeaway ๐ฅก message: peripheral vasopressors are safe #CCR23
Great to hear #CLOVERS study discussed in depth at @CritCareReviews today.
Some answers and some more questions generated about early fluid resuscitation in adults with septic shock.